Alpha Mark Advisors, LLC Emergent Bio Solutions Inc. Transaction History

Alpha Mark Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$55.63 - $73.24 $610,761 - $804,101	-10,979 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$52.05 - $66.51 $28,523 - $36,447	-548 Reduced 4.75%	10,979 $723,000
Q4 2017 Feb 09, 2018	BUY	$37.77 - $47.75 $435,374 - $550,414	11,527	11,527 $536,000

157

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $542M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Mark Advisors, LLC with notifications on news.